| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Hospital & Healthcare Services
|
Compare with Industry peers |
| Website | http://www.vimta.com | |
| Market Cap | 1,204.42 Cr. | |
| Enterprise Value(EV) | 1,231.82 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 18.65 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 29.13 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 67.10 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 138.42 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 3.92 | Calculated using Price: 543.25 |
| Dividend Yield | 0.37 | Period Ending 2023-03 |
| No. of Shares Subscribed | 2.22 Cr. | 22,170,583 Shares |
| FaceValue | 2 | |
| About Vimta Labs Ltd. | ||
| Vimta Labs is India's leading contract research and testing organization. Established in 1984, Vimta has an envious track record of serving several market leaders across the globe. | ||
| 1 Day |
|
-3.82% |
| 1 Week |
|
+18.24% |
| 1 Month |
|
+20.02% |
| 3 Month |
|
+26.04% |
| 6 Month |
|
+6.89% |
| 1 Year |
|
+43.05% |
| 2 Year |
|
+49.48% |
| 5 Year |
|
+178.24% |
| 10 Year |
|
+475.19% |
| 4 years | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 3.96 | 11.66 | 19.43 | 19.02 | |
| Return on Capital Employed (%) | 5.84 | 14.25 | 23.92 | 24.59 | |
| Return on Assets (%) | 2.79 | 8.25 | 14.29 | 14.53 |
| Particulars | 5 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 173 | 194 | 234 | 282 | 297 | |
| Non Curr. Liab. | 15 | 25 | 23 | 19 | 16 | |
| Curr. Liab. | 58 | 54 | 48 | 57 | 58 | |
| Minority Int. | ||||||
| Equity & Liab. | 245 | 273 | 305 | 358 | 371 | |
| Non Curr. Assets | 149 | 163 | 181 | 194 | 216 | |
| Curr. Assets | 96 | 111 | 124 | 164 | 155 | |
| Misc. Exp. not W/O | ||||||
| Total Assets | 245 | 273 | 305 | 358 | 371 |
| Particulars | 5 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 181 | 211 | 278 | 318 | 320 | |
| Other Income | 3 | 1 | 1 | 3 | 4 | |
| Total Income | 184 | 212 | 280 | 322 | 325 | |
| Total Expenditure | -151 | -158 | -198 | -223 | -234 | |
| PBIDT | 33 | 54 | 82 | 98 | 91 | |
| Interest | -4 | -2 | -2 | -3 | -2 | |
| Depreciation | -21 | -23 | -23 | -31 | -34 | |
| Taxation | -1 | -7 | -14 | -17 | -13 | |
| Exceptional Items | -1 | |||||
| PAT | 7 | 21 | 41 | 48 | 41 | |
| Minority Interest | ||||||
| Share Associate | ||||||
| Other Related Items | ||||||
| Consolidated Net Profit | 7 | 21 | 41 | 48 | 41 | |
| Adjusted EPS | 3 | 10 | 19 | 22 | 19 |
| Particulars | 4 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 24 | 37 | 59 | 88 | |
| Cash Fr. Inv. | -21 | -32 | -38 | -57 | |
| Cash Fr. Finan. | -1 | -5 | -17 | -11 | |
| Net Change | 3 | 1 | 5 | 20 | |
| Cash & Cash Eqvt | 6 | 6 | 11 | 31 |
|
Thu, 25 Apr 2024
Spurt in Volume Significant increase in volume has been observed in Vimta Labs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Vimta Labs Limited has submitted their response. |
|
Thu, 25 Apr 2024
Spurt in Volume Significant increase in volume has been observed in Vimta Labs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. |
|
Sat, 13 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018 Vimta Labs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
| Thu, 25 Apr 2024 |
Higher Delivery Quantity
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
Closing Above Previous High
|
Closing Above Previous High For 3 Days
|
